The biopharmaceutical cartel and high drug prices

Forbes

10 April 2019 - Given the attacks on the biopharmaceutical industry by “pharmascolds”, one would think that all of the negative terms that can be used to describe the nefarious nature of the industry have already been used. 

However, Gary West of West Health seems to have come up with a new twist with his use of drug cartels to describe what some believe is an important part of the health care system. Here is what he had to say in a recent op-ed piece in the San Diego Union Tribune.

“The U.S. health care industry keeps prices artificially high and competition low, operating by the dictionary definition of a cartel: ‘An association of manufacturers or suppliers with the purpose of maintaining prices at a high level and restricting competition.’ “

West describes that the cartel operates by invading Washington with hordes of lobbyists with big budgets to preserve the status quo.

Read Forbes article

Michael Wonder

Posted by:

Michael Wonder